CONSUMER LAW GROUP has filed a Canadian class action lawsuit against against the makers of the drug Yaz (drospirenone and ethinyl estradiol), manufactured by Bayer and Berlex, on behalf of individuals who have suffered from a condition known as hyperkalemia (an increase in potassium level in the blood), or problems related to the drugs’ diuretic qualities, or problems related to the drugs’ hormonal misbalance.
Hyperkalemia, diuretic issues, and hormonal imbalances can lead to the following health problems:
• Deep vein thrombosis
• Blood clots
• Pulmonary embolism
• Heart attacks
• Stroke
• Gallbladder problems and infections
• Liver failure
• Kidney failure
• Severe anxiety
• Depression
• Sudden death
For more information, please visitt our CLG website at http://www.clg.org/
JOIN THIS CLASS ACTION TODAY
All residents in Canada who who have taken and/or purchased the drugs Yaz and/or Yasmin (drospirenone and ethinyl estradiol) since January 12th 2005 and their successors, assigns, family members, and dependants are encouraged to sign up for this class action in order to receive compensation.
Only those persons that join the class action and provide their contact information will be eligible for benefits.
Only those persons that join the class action and provide their contact information will be eligible for benefits.
Do not miss out. Please go to http://www.clg.org/Class-Action/List-of-Class-Actions/Yaz-/-Yasmin-Drug-Side-Effects-Class-Action
Subscribe to:
Posts (Atom)